Myomo said this is a 128% increase year over year and the highest quarterly revenue in the company’s history.
Myomo reaches $3.1 million in sales in second quarter
Myomo recognized revenue on 80 units in the second quarter, an increase of 233% compared with the second quarter of 2020.
Medicare provider certification granted to wearable robotics firm Myomo
Myomo, which makes wearable robots offering increased functionality for people with neurological disorders or upper-limb paralysis, said Medicare authorization is an important step toward reimbursements.
The Robot Report August 2019 issue on exoskeletons
In this month’s issue of The Robot Report, a special print insert in Design World, we examine exoskeleton design, development, and uses in healthcare and industry.
Myomo scales up production, training for MyoPro device for upper-body mobility
Myomo is working with contract manufacturers for its MyoPro assistive devices, which use sensors, algorithms, and motors to help wearers regain upper-limb function.
Robotics investments February 2019
Robotics investments totaled at least $4.3 billion in February 2019 in a steep increase from January, which had about $1.4 billion. In addition, companies reported approximately $3.9 billion worth of acquisitions this past month. Any political or economic jitters have not yet harmed the mood for robot deals. The Robotic Industries Association noted yesterday that robot…
Myomo prices upcoming $10m offering
Myomo today priced an upcoming offering, looking to raise approximately $10 million to support its myoelectric braces and orthotics designed for individuals with neuromuscular disorders. In the offering, the Cambridge, Mass.-based company is looking to float approximately 4.2 million shares and warrants to purchase an additional 4.2 million shares at $2.40 per share. Warrants offered…
Myomo readies $17m offering
Myomo said late last week it is looking to raise approximately $17.4 million in a new offering of shares and warrants to support its myoelectric braces and orthotics designed for individuals with neuromuscular disorders. In the offering the company plans to float approximately 1.5 million shares of common stock and warrants to purchase an additional…